Pubblicazioni

Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies

2022 - EXPERT OPINION ON PHARMACOTHERAPY
Elia, G.; Ferrari, S. M.; Ragusa, F.; Paparo, S. R.; Mazzi, V.; Ulisse, S.; Benvenga, S.; Antonelli, A.; Fallahi, P.

Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders

2021 - EXPERT OPINION ON PHARMACOTHERAPY
Schroder, C. M.; Banaschewski, T.; Fuentes, J.; Hill, C. M.; Hvolby, A.; Posserud, M. -B.; Bruni, O.

An update on the pharmacological management of pain in patients with multiple sclerosis

2020 - EXPERT OPINION ON PHARMACOTHERAPY
Chisari, C. G.; Sgarlata, E.; Arena, S.; D'Amico, E.; Toscano, S.; Patti, F.

Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia

2020 - EXPERT OPINION ON PHARMACOTHERAPY
D'Erasmo, L.; Gallo, A.; Di Costanzo, A.; Bruckert, E.; Arca, M.

Current pharmacological approaches to the treatment of tendinopathy

2020 - EXPERT OPINION ON PHARMACOTHERAPY
Aicale, R.; Bisaccia, R. D.; Oliviero, A.; Oliva, F.; Maffulli, N.

Switching antipsychotic medication to aripiprazole. position paper by a panel of Italian psychiatrists

2015 - EXPERT OPINION ON PHARMACOTHERAPY
Fagiolini, Andrea; Brugnoli, Roberto; Di Sciascio, Guido; DE FILIPPIS, Sergio; Maina, Giuseppe

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma